U.S. flag

An official website of the United States government

NM_000212.3(ITGB3):c.718C>T (p.Arg240Trp) AND Glanzmann thrombasthenia

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Aug 20, 2024
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001580253.3

Allele description [Variation Report for NM_000212.3(ITGB3):c.718C>T (p.Arg240Trp)]

NM_000212.3(ITGB3):c.718C>T (p.Arg240Trp)

Gene:
ITGB3:integrin subunit beta 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.32
Genomic location:
Preferred name:
NM_000212.3(ITGB3):c.718C>T (p.Arg240Trp)
Other names:
R214W
HGVS:
  • NC_000017.11:g.47286363C>T
  • NG_008332.2:g.37522C>T
  • NM_000212.3:c.718C>TMANE SELECT
  • NP_000203.2:p.Arg240Trp
  • LRG_481:g.37522C>T
  • NC_000017.10:g.45363729C>T
  • NC_000017.10:g.45363729C>T
  • NM_000212.2(ITGB3):c.718C>T
  • NM_000212.2:c.718C>T
  • P05106:p.Arg240Trp
Protein change:
R240W; ARG214TRP
Links:
UniProtKB: P05106#VAR_004000; OMIM: 173470.0003; dbSNP: rs121918446
NCBI 1000 Genomes Browser:
rs121918446
Molecular consequence:
  • NM_000212.3:c.718C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Glanzmann thrombasthenia
Synonyms:
PLATELET GLYCOPROTEIN IIb-IIIa DEFICIENCY; Thrombasthenia of Glanzmann and Naegeli; Glanzmann thrombasthenia type A; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0100326; MedGen: C0040015; Orphanet: 849; OMIM: PS273800

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001809897ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(ClinGen Platelet ACMG Specifications v2-1)
Likely Pathogenic
(Aug 20, 2024)
germlinecuration

Citation Link,

SCV004848913Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Feb 2, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen, SCV001809897.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The NM_000212.2(ITGB3):c.718C>T (p.Arg240Trp) missense variant has been reported in at least five patients (PMID: 32200672, 7509233, 1602006, doi.org/10.2491/jjsth.10.243, and a thesis by Zapelli in 2014) with a phenotype highly specific to GT. Several probands from PMID: 32200672, PMID: 7509233, and PMID: 1602006 are homozygous (PM3) and meet the criteria for PP4_moderate; including mucocutaneous bleeding and impaired aggregation with all agonists except ristocetin. Additionally, surface αIIbβ3 was dysfunctional as shown by defective PAC-1 and fibrinogen binding. This variant is at an extremely low frequency (below the <1/10,000 threshold) with a MAF of 0.00002196 (2/91,084 alleles) in the gnomADv4.1.0 South Asian population (PM2_supporting). It is predicted to have a deleterious effect (REVEL score 0.832; PP3) and occurs at the same residue as pathogenic variant Arg240Gln (PM5). In summary this variant meets criteria to be classified as likely pathogenic for GT. GT-specific criteria applied: PM2_Supporting, PM3, PM5, PP3, and PP4_Moderate.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, SCV004848913.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.Arg240Trp variant in ITGB3 has been reported in 3 homozygous individuals with Glanzmann thrombasthenia (Lanza 1992 PMID: 1602006, Paciullo 2021 PMID: 32200672, Djaffar 1993 PMID: 7509233). It was also identified 0.001% (1/68038) of European chromosomes by gnomAD, v.3 (http://gnomad.broadinstitute.org). The variant is also reported in ClinVar, and has been classified as pathogenic by the ClinGen Platelet Disorders Variant Curation Expert Panel (Variation ID 13555). In vitro analysis using patient derived platelets support an impact to normal protein function. Computational prediction tools and conservation analysis suggest that this variant may impact the protein. Another variant involving this codon (p.Arg240Gln) has been identified in individuals with Glanzmann thrombasthenia and is classified as pathogenic by the ClinGen Platelet Disorders Variant Curation Expert Panel. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Glanzmann thrombasthenia. ACMG/AMP criteria applied: PM3, PM5, PS3_Supporting, PM2_Supporting, PP3, PP4.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024